Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

HT KIT

Next Previous
Drug Profile

HT KIT

Alternative Names: HT-KIT mRNA Frame Shifting Therapeutic

Latest Information Update: 23 Sep 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator North Carolina State University
  • Developer Hoth Therapeutics
  • Class Antineoplastics; Antisense oligonucleotides; Morpholines; Skin disorder therapies
  • Mechanism of Action Gene silencing; Proto-oncogene protein c-kit expression inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Mastocytosis
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Gastrointestinal stromal tumours
  • No development reported Anaphylaxis; Leukaemia; Mastocytosis

Most Recent Events

  • 23 Sep 2025 Hoth Therapeutics has patent protection for HT KIT in Japan
  • 28 Jul 2025 No recent reports of development identified for preclinical development in Anaphylaxis in USA (Parenteral)
  • 28 May 2025 No recent reports of development identified for preclinical development in Leukaemia in USA (Parenteral)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top